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ABSTRACT
Staphylococcus aureus is an important human pathogen that causes wide arrays of
infections ranging from minor skin infections to lethal systemic conditions such as
infective endocarditis, osteomyelitis, sepsis and pneumonia. These systemic diseases are
often difficult to treat due to the presence of persister cells. Persister cells are a
phenotypic variant of the bacterial population that exhibit extreme and transient antibiotic
tolerance accompanied by a transient halt in growth. Upon cessation of antibiotic
treatment, however, persisters resume growth which results in recurrence of infections.
This characteristic of persister cells therefore displays high clinical significance. In this
study, we show the involvement of the msaABCR operon in antibiotic tolerance in S.
aureus under the clinically relevant bactericidal antibiotic gentamicin. In previous study,
the msaABCR operon was found to involve in persister cells formation such that the
deletion of the msaABCR operon showed decreased persister formation in the methicillin
resistant S. aureus (MRSA) strain USA300 LAC (Sahukhal et al. 2017). The RNA
transcriptome of the msaABCR deletion mutant showed differential expression of genes
that are involved in various metabolic pathways including carbohydrate, amino acid
pathways (Sahukhal et al 2017). Considering the importance of metabolism in antibiotic
tolerance, first we examined the expression of tricarboxylic acid (TCA) genes to measure
the TCA cycle activity. The qRT-PCR results showed that the msaABCR deletion mutant
indeed has increased expression of TCA genes and higher ATP content (Sahukhal et al.,
2017). Furthermore, we evaluated the antibiotic tolerance in TCA cycle mutants in S.
aureus. The results showed that the transposon mutants of TCA cycle genes exhibit
higher antibiotic tolerance as compared to the wild type USA300 LAC. Considering the
iv

importance of energy content in the antibiotic tolerance, we also measured the ATP
content and membrane potential. Deletion of TCA genes leads to decreased cellular ATP
content as well as reduced membrane potential. We also observed increased pigment
production and biofilm production in the TCA mutants. Altogether, these results suggest
that the reduced metabolic activity contributes to the antibiotic tolerance as well as
virulence in S. aureus.
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CHAPTER I – INTRODUCTION
1.1 Staphylococcus aureus
S. aureus is a gram-positive coccus, non-motile and non-spore forming bacterial
pathogen that belongs to the Firmicutes phylum and Bacilli class. This bacterium is
facultative anaerobe measuring 0.7-1.2 μm in diameter. S. aureus is the most common
pathogen among Staphylococcus genus that causes wide arrays of infections in human.
In 1882, Ogston examined pus from a surgical abscess and named these bacteria
“staphylococci”, derived from the Greek words staphyle, referring to “the bunch of
grape”, and kokkos denoting “berry”, referring to the bacterial structures as observed
under microscope (Ogston, 1882). In 1884, Rosenbach noted white and pigmented
staphylococci. The species that showed the golden pigmented colonies was then named S.
aureus, derived from the Latin word aurum meaning “gold” (Licitra, 2013). In 1903,
Loeb observed coagulation of blood by S. aureus (Loeb, 1903), which is widely known
as the coagulase test (clotting of blood plasma) to differentiate S. aureus from other
coagulase negative staphylococci (CNS) (Loeb, 1903). Likewise, S. aureus produces a
catalase enzyme, and this property is tested to differentiate the pathogen from
streptococci.
S.aureus is an important human pathogen that can cause wide arrays of infection
ranging from the minor skin infections to often lethal systematic infections such as
osteomyelitis, sepsis, infective endocarditis and pneumonia (Lowy, 1998). S. aureus are
also commensal bacteria found amongst 30% of the human population (Gorwitz et al.,
2008; Kluytmans et al., 1997). However, underlying immunocompromised conditions or
loss of skin barrier may result in S. aureus opportunistic infections in an individual.
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1.1.1 S. aureus is a Health Burden Worldwide
S. aureus is a major bacterial pathogen that can cause a remarkably diverse array
of infections ranging from acute skin infections to systemic and often life-threatening
conditions such as endocarditis, bacteremia, osteomyelitis and pneumonia (Lowy, 1998).
S. aureus is the prime causative agent of bacteremia and infective endocarditis (Tong et
al., 2015). In addition to this, the bacteria are also a major source of osteoarticular
infections, pleuropulmonary infections, skin and soft tissue infections, and surgical
device related infections (Tong et al., 2015). Despite the clinical relevance, there is an
absence of an effective vaccine against S. aureus.
The ability of S. aureus to cause a variety of infections is mainly due to various
virulence factors, antibiotic resistance, and their ability to escape the host immunity
(Foster, 2009; Johnson, 2011; Lowy, 1998). Immunocompromised individuals with
underlying conditions such as diabetes, vascular diseases, cancer or the patients
prescribed with hospital devices such as tips or catheters have a higher risk of getting S.
aureus infections (https://www.cdc.gov/hai/organisms/staph.html). S. aureus was further
reported to be the major cause of healthcare associated (HA) infections. In addition,
within the past decade, community acquired (CA) S. aureus infections have been
consistently increasing. In 2004, the methicillin resistant S. aureus (MRSA) strain
USA300 was reported to be the most common cause (more than 98%) of the emergency
cases in soft tissue infections in 11 cities in the US (Moran et al., 2006). In 2017, Centers
for Disease Control and Prevention (CDC) reported >119,000 MRSA associated
bacteremia cases with ~20,000 deaths in the U. S. alone (Kourtis AP, 2019).
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Additionally, MRSA is also reported to be the leading cause of infective
endocarditis, accounting for ~50,000 incidences per year. The annual treatment cost for
MRSA infections was reported to range between 4 to 30 billion dollars in the US alone
(Moran et al., 2006). Due to its ability to cause severe diseases, S. aureus infections result
in high morbidity and mortality rates, thus imposing a high socio-economic burden
worldwide (Kourtis et al., 2019). In addition to North America, CA-MRSA has also been
reported in Asia, Europe, South America, and Australia (Chambers & Deleo, 2009).
1.2 Persister Cells
Persister cells are a phenotypic variant of the bacterial population that are
extremely tolerant to antibiotics. This tolerance property is transient and is accompanied
by a transient halt in growth. Persister cells are characterized as dormant, non- growing
cells (Brian P. Conlon, 2014). When a bacterial culture is exposed to a lethal
concentration of bactericidal antibiotic, a bulk of the population is killed. However, a
small fraction of cells are left intact form a characteristic persister plateau. This antibiotic
tolerance property gives rise to a characteristic biphasic killing curve during in vitro
experiments (Kim Lewis, 2010). Once antibiotic treatment is discontinued, the dormant
persister cells are capable of resuming growth and producing a cell population identical
to that of the original (Shah et al., 2006). The population produced by the persister cells
has also been found to have a similar fraction of antibiotic tolerant vs non tolerant cells to
that of the original population (Iris Keren et al., 2004).
Persister cells behave in a manner that allows them to avoid antibiotic killing
without genetic modification (Balaban et al., 2004). Antibiotics commonly used on S.
aureus infections were manufactured to target the mechanisms and processes that are
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active during cellular growth (Fauvart et al., 2011). Since persister cells undergo
dormancy, antibiotics therefore become ineffective against this specific population
(Fauvart et al., 2011).
Because persister cells contain the ability to tolerate antibiotic exposure for
extended periods of time and regrow upon the removal of antibiotic treatment, persister
cells are thought to be one of the major causes of reoccurring S. aureus infections (I.
Keren et al., 2004; Wood et al., 2013). The mechanism concerning persister cell
formation is not directly understood, but there is evidence that factors such as reduced
ATP concentrations contribute to the antibiotic tolerance (Brian P. Conlon et al., 2016).
1.2.1 Mechanisms Underlying Persister Formation is Poorly Understood
Although the persister phenomenon was discovered more than 70 years ago, the
mechanisms of persister formation in S. aureus are not well understood. Previously,
stringent response or dormancy were regarded as the contributing factors for bacterial
persistence. However, recent studies have challenged these findings such that the deletion
of toxin-antitoxin systems did not decrease persister formation (Dawson et al., 2011;
Harms et al., 2017; Svenningsen et al., 2019; Wood et al., 2013); making a persister
switch even more of an elusive bacterial phenomenon. Therefore, understanding the
mechanisms of persister formation has been extremely challenging, mainly due to their
transient nature and small population size.
1.2.2 Reduced Metabolism Increases Persister Cells Formation
Recently, an increasing number of studies have examined the contribution of
metabolic genes in the formation of S. aureus persister cells. For example, Yee et al.
reported the contribution of purine genes in persister cell formation (Yee et al., 2015).
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Wang et al. showed that inactivation of succinate dehydrogenase (sdhA/B) forms a lower
population of persister cells against different stressors, including antibiotics (Wang et al.,
2015). Likewise, the mutant of phoU showed decreased persisters due to increased
metabolic activity (Shang et al., 2020). Recent studies have found that the environmental
conditions that have normally been correlated with interrupting transcription, translation
or the synthesis of ATP actually increase persister fraction (B. P. Conlon et al., 2016;
Shan et al., 2017; Wood et al., 2013). Studies have shown that the inactivation of TCA
cycle genes drastically increases persister cells ((Wang et al., 2018; Zalis et al., 2019). A
decrease in ATP levels has resulted in a higher persister cell frequency during the
exponential growth phase (B. P. Conlon et al., 2016; Zalis et al., 2019), while also noting
that persister cell frequency is characterized by lower membrane potentials during the
stationary phase or in a polymicrobial culture (Nabb et al., 2019; Wang et al., 2018). The
reduced ATP level as the cause for increased persister fraction was also observed in the
mutant of carbamoyl phosphate synthetase (carB) in the major pathogens S. aureus, E.
coli, and P. aeruginosa (Cameron et al., 2018). These findings highlight the importance
of metabolism in persister formation such that the inactivation of TCA enzymes result in
a drastic increase in persister frequency.
1.3 Staphylococcal Virulence Factors
Virulence factors are defined as the molecules that increase the potential of a
pathogen to cause disease (Heilmann, 2011). Virulence factors have been known to
transfer from one strain to another through a process called horizontal gene transfer
(Morikawa et al., 2012). S. aureus possess a plethora of virulence factors including but
not limited to: the production of biofilms, capsules, pigments and proteases. Each of these
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virulence factors help S. aureus to cause various diseases by aiding in averting the host
defense systems (Otto, 2014).
1.3.1 Role of Biofilms in Antibiotic Tolerance
S. aureus biofilms are composed of a matrix of bacteria derived from extracellular
polysaccharides, proteins, DNA and host-derived fibrin matrices. These structures
provide environmental niches such as low nutrient level and gradient of pH (Kavanaugh
& Horswill, 2016). Such unfavorable conditions provide a selection pressure for the
generation of antibiotic insensitive persister cells, which are metabolically inactive with
the presence of reduced ATP content (Lewis, 2008; Waters et al., 2016). Since the
biofilms disperse, these infections can also result in metastatic infections (Lewis, 2001;
K. Lewis, 2007).
Considering the importance of biofilms in treatment failures, several approaches
have been proposed to effectively kill persisters within S. aureus biofilms. For example,
Study by Allison et al. in a mouse catheter model showed the eradication of the persisters
by potentiating the aminoglycosides drugs with the addition of metabolites such as
fructose and mannitol. These metabolites were shown to enhance the gentamicin uptake
via generation of proton motive force (PMF) resulting into eradication of S. aureus and E.
coli biofilms (Allison et al., 2011). Likewise, L-arginine via pH mediated mechanism was
also shown to facilitate biofilm eradication by gentamicin in catheter-based biofilms
formed in mice (Lebeaux et al., 2014). Another approach used an energy independent
synthetic acyldepsipeptide antibiotic ADEP4 that could degrade more than 400 proteins.
In combination with rifampicin, ADEP4 was shown to eradicate catheter model infection
in mice (Conlon et al., 2013). The undeniable link between the recalcitrance of chronic
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infections and persister formation is what sparked further research into the topic of
persister cells, as well as the urgency to understand the mechanisms behind their
formation (Lafleur et al., 2006; Kim Lewis, 2007).
1.4 Role of the msaABCR Operon in Persister Cells Formation
The msaABCR operon comprises four genes (msaA, msaB, msaC and anti-sense
msaR) were identified and characterized by the Elasri research group (Sahukhal & Elasri,
2014). Among these four genes, msaB encoding MsaB (also known as CspA) is the only
protein coding gene. However, msaC, is a non-protein coding RNA that is essential to
regulate the function of the msaABCR operon. The anti-sense msaR that is
complementary to the 5’end of the msaB expresses differentially based on the growth
phase of S. aureus (Sahukhal & Elasri, 2014). Previous studies conducted in Elasri lab
have demonstrated the role of the msaABCR operon in biofilm development (Sahukhal et
al., 2015; Sahukhal & Elasri, 2014), capsule production (Batte et al., 2018), and antibiotic
resistance and tolerance in S. aureus. The deletion of the msaABCR operon was found to
form decreased persister cells in both planktonic and biofilm growth conditions as
compared to the wild type USA300 LAC in the presence of several clinically relevant
antibiotics (Sahukhal et al., 2017).
In this study, we examine the role of msaABCR in TCA cycle activity.
Furthermore, using the TCA mutants, we also show the importance of metabolism in
virulence of S. aureus. Altogether, this study suggests that the msaABCR operon plays
role in the adaptation of S. arureus in different environmental stressors as well as via
producing several virulence factors that aid the pathogens in invading or evading the host
defense systems.
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CHAPTER II-MATERIALS AND METHODS
2.1 Growth Conditions and Bacterial Strains
The bacterial strains used for the study were methicillin-resistant Staphylococcus
aureus (MRSA) USA 300 LAC, isogenic msaABCR operon mutant (msaABCR) and the
complement of the operon strain (complementation). First of all, the cultures of S. aureus
cells were prepared by inoculating cells from frozen culture. The cells from the frozen
culture were placed into 5 ml fresh tryptic soy broth (TSB; Becton, Dickinson and
Company, MD, USA) and incubated at 37 C with continuous shaking at a 225 rpm.
After 2-3 h of incubation, cells were normalized to OD600 nm of 0.05 in 5 ml TSB and
incubated further for 16 h to prepare the stationary phase culture. Bacterial strains used in
this study are listed in Table 3.2.
The production of the msaABCR operon deletion in USA300 LAC achieved
through the allelic replacement method as previously described (Batte et al., 2016;
Sahukhal & Elasri, 2014). The ORF of the msaABCR operon region was then cloned into
the pCN34 low-copy-number vector for trans-complementation. For this process, the
kanamycin selectable marker was changed to a chloramphenicol resistance marker.
2.2 Generation of Transposon Mutants
The plasmid-cured derivatives of the LAC strain JE2 carrying transposon
mutations in the specific coding regions of the desired genes were acquired from the
Network of Antimicrobial Resistance in the S. aureus (NARSA) collection. The
mutations were transferred to USA300 LAC strain or UAMS-1 strain through the
generalized transduction process. The bacteriophage φ11 was utilized in this process.
Through amplification of the beginning and end of the open reading frame (ORF) for the
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designated genes, the transduction of the mutation into the desired strains was confirmed
by end-to-end PCR as described previously (Batte et al., 2016; Pandey et al., 2019).
2.3 Persister Assay
The pre-cultures prepared as mentioned above were normalized to OD600 nm
value of 0.05 in 5 ml of TSB at a flask-to-medium ratio of 10:1. After normalization, the
cultures were then incubated at 37 C until stationary growth phase (16 h). The cultures
were standardized in 3 ml of TSB. For the measurements of initial colony forming units
(CFUs) count, 100 μl of the standardized culture was withdrawn before adding
antibiotics, and serial diluted in 900 μl of 1 × phosphate buffer saline (PBS) and plated
on the tryptic soy agar (TSA) plates. The rest of the cultures were then exposed to
gentamicin (20 μg/ml, 20 × MIC). Then the cultures were incubated at 37 C with
continuous shaking. At the designated time after exposure to the antibiotic, 100 μl of each
sample was removed and washed with 900 μl of 1× PBS. These samples were then plated
and incubated for 24 h to obtain final CFUs count.
Stationary phase cells were exposed to 10 μM carbonyl cyanide m-chlorophenyl
hydrazone (CCCP) or different concentration of fumarate (15 mM, 30mM and 50 mM)
for a thirty minute before exposure to gentamicin. At 24 h post exposure, 100 μl of cells
were collected, washed, and plated to obtain a value for the CFUs.
2.4 Measurement of pH and acetate
Cells grown until stationary phase in 5 ml TSB as mentioned above were
centrifuged and the supernatant was transferred to new tube. Then pH in the supernatant
was measured by Accumet with Fisher brand pH meter. Similarly, cells grown to
stationary phase were centrifuged and the supernatant was preserved in -80°C to measure
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the acetate accumulation. The acetate was measured in the preserved culture supernatant
according to the manufacturer instruction (R-biopharm, Washington, MO).
2.5 RNA Extraction, Reverse Transcription, and qRT-PCR
From the appropriate growth cultures, 500 μl amounts were treated with
RNAprotect bacterial agent (Qiagen, Valencia, CA) for 5 minutes at room temperature.
Extracting of the total RNA was done through the use of the Qiagen RNeasy kit (Qiagen),
and the extracted RNA was analyzed with the NanoDrop spectrophotometer (ThermoScientific) in order to observe the quality and concentration of the extracted RNA. The
iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA) was used for reverse
transcription. This process was done by using 1 μg of the total RNA according to the
instructions provided by the manufacturer. SYBR Green supermix (Bio-Rad) was used to
do qRT-PCR. The relative fold change for gene expression was then calculated through
the use of gyrB as an endogenous control gene. The primers used in this study are listed
in table 3.2.
2.6 Measurement of ATP
The BacTiter-Glo kit (Promega, WI, USA) was used to measure the value for
intracellular ATP content. At the designated phase, the cells were adjusted to an OD600
nm of 0.025 in 1 ml of TSB. From there, 50 μl aliquots were transferred into the wells of
an opaque 96-well plate and mixed with the BacTiter-Glo Reagent. The resultant
luminescence was measured at OD560 nm after a 5 minute incubation at room
temperature.
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2.7 Measurement of Membrane Potential
The BacLight Bacterial Membrane Potential kit (Life Technologies, USA) was
used to examine membrane potential. The cells when reached stationary phase were
washed and normalized to OD600nm of 1.0 in 0.5 ml of filtered PBS. After resuspension,
16.6 μl of fluorescent membrane potential indicator dye 3,3’- diethyloxacarbocyanine
iodide (DIOC2 (3)) were added and then incubated for 30 minutes at room temperature.
The fluorescent signals were recorded for 100,000 cells through the use of a LSRFortessa
flow cytometer (BD Biosciences, CA, USA). The negative control cells were incubated
in 10 μm CCCP for 30 minutes before adding (DIOC2 (3)). The ratio for red fluorescence
(PE-A) to green fluorescence (FITC) was calculated and analyzed through the use of
FlowJo v10 software.
2.8 Statistical Analysis
The GraphPad Prism software was used to analyze the data. Specifically, the
student’s t-test (unpaired) or one-way analysis of variance (ANOVA) accompanied by
Tukey’s multiple comparison test with a p value of less than 0.05 being considered as
statistically significant.
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CHAPTER III-RESULTS
3.1 Measurement of growth kinetics and minimum inhibitory concentration (MIC)
values
Before conducting persister assays, we measured the growth kinetics of the
mutant of TCA genes citrate synthase (encoded by gltA), succinate dehyderogenase
(sucA) and fumarate hydratase (fumC) in the nutrient rich medium TSB. To represent the
early, middle and late genes in the TCA cycle, these genes were chosen in this study. The
results show that although the exponential growth was similar to the wild type USA300
LAC, the gltA and fumC mutant showed reduced growth rate as compared to the wild
type USA300 LAC measured in the stationary phase (Fig. 3.1). Considering the clinical
relevance of antibiotic tolerance, in this study we measured the persister frequency in the
presence of aminoglycoside drug gentamicin. To determine the MIC values, standard
micro-broth dilution method was followed. Deletion of the msaABCR operon as well as
the TCA genes gltA, sucA and fumC did not change the susceptibility of S. aureus
towards gentamicin (Table 3.1).
Table 3.1 Minimum Inhibitory Concentration (MIC) value of gentamicin
Minimum Inhibitory Concentration of gentamicin
Strains

(μg/ml)

USA300 LAC
msaABCR
Complementation
gltA
sucA
fumC

1
1
1
1
1
1
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Considering the importance of growth of bacterial cells in persister formation, we
also examined the growth kinetics of all the strains in the nutrient rich medium TSB in
the absence of antibiotics. The results show that the inactivation of gltA and fumC
reduced the growth rate in USA300 LAC while sucA showed similar growth kinetics as
comparable to the wild type (Fig. 3.1).

USA300 LAC

12

msaABCR

OD600 nm

10

gltA
sucA

8

fumC

6
4
2
0
0

1

2

3

4

6

8

10

12

24

48

Time (h)
Figure 3.1 Measurement of growth kinetics
Growth rate measurement in nutrient rich TSB medium until the stationary-phase of growth (48 h). The
normalized cultures were incubated at 37° C and the absorbance of the culture was taken at OD600 nm
each hour. Data represents the OD600 nm readings at the designated time points. Error bars represent
standard error (SE) of the mean of the three replicates.

3.2 The msaABCR mutant has higher TCA cycle activity and the cellular ATP level
Previous study showed the involvement of the msaABCR operon in persister cells
formation. Given that the persister cells is associated with the depletion of energy, we
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hypothesized that the deletion of the msaABCR operon in S. aureus cells results in
increased metabolic activity resulting in decreased persisters in the msaABCR mutant. To
test this, we measured the TCA cycle activity by measuring the expression of the TCA
genes. Since, the TCA cycle is activated during the late exponential phase to generate
ATP when glucose is depleted; we measured the expression of TCA genes citrate
synthase (gltA), aconitate hydratase (acnA), isocitrate dehydrogenase (icd), 2oxoglutarate (sucA), succinyl-CoA synthetase (sucD), succinate dehydrogenase (sdhA/B),
and fumarate hydratase (fumC) during this growth phase. The qRT-PCR results show
increased expression of these genes in the msaABCR mutant compared to the wild type
USA300 LAC (Figure 3.2A). Furthermore, we also measured the ATP and found that the
msaABCR mutant contains higher ATP levels relative to the USA300 LAC strain in the
late exponential growth (Figure 3.2B).

Figure 3.2 Measurement of TCA cycle activity and intracellular ATP level
Fold change expression of TCA genes (gltA, acnA, icd, sucA, sucD, sdhA/B, and fumC) in late exponential
growth phase for the msaABCR mutant compared with the USA300 LAC strain, as measured by qRT-PCR.
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(B) The ATP concentrations per CFU of all strains in late exponential phase. The data represent the average
of three measurements with two biological replicates. Error bars represent the standard error of the mean
(SEM) for three independent experiments. Statistical significance was determined using analysis of
variance (ANOVA) followed by Tukey’s multiple comparison test. *, P ≤0.05; ns, not significant.

3.3 Inactivation of TCA genes increases persister formation
Since, we observed increased expression of TCA genes in the msaABCR mutant,
we sought to examine the role of the TCA genes in antibiotic tolerance. For this, we
performed the persister assay in mutants of the TCA cycle genes gltA, sucA and fumC in
USA300 LAC background in the presence of gentamicin. Consistent with the previous
studies, the results showed that the inactivation of TCA genes drastically increases the
persister formation in USA300 LAC (Fig. 3.3).

Figure 3.3. Persister assay in TCA mutants in the stationary phase of growth.
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Cells grown to stationary phase (16 h) were standardized and were exposed to antibiotic gentamicin (20 ×
MIC). At 24 h post exposure, cells were harvested, washed in PBS and serially diluted and plated for the
persister count. The data represent the fraction of surviving cells as compared to the initial count (before
adding antibiotic). Error bars represent the mean of the standard error (SEM) of at least three replicates.

These results show the importance of metabolic genes in the persister formation
such that the inactivation of TCA genes lead to increased persister formation.
3.4 Addition of fumarate increases persister formation
Previous studies have shown variation in persister formation in E. coli and P.
aeruginosa by intracellular fumarate concentration (Kim et al., 2016; Meylan et al.,
2017). To test whether fumarate increases the persister formation in S. aureus cells, we
measured the persister frequency in presence of exogenously added fumarate. Our results
show that addition of fumarate increased the persister frequency in dose dependent
manner both in wild type and msaABCR mutant (Fig. 3.4).

Figure 3.4 Exogenously added fumarate increases the persister frequency
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Cells grown to the late exponential phase were divided into two tubes (3 ml each) and exposed to
gentamycin and gentamycin with fumarate. The persister frequency was estimated by taking c.f.u counts
after 24 h of treatment. Data represent average of three independent experiments. Error bars represent SE.
Statistical significance was determined using students t-test to compare the result of msaABCR mutant to
the wild type. **, P ≤0.005.

3.5 The TCA mutants show decreased pH accompanied by increased acetate content
in the stationary growth phase
In S. aureus, the TCA cycle is activated when glucose is depleted, and acetate is
being catabolized. Deletion of TCA genes therefore obstructs the catabolism of acetate
that is accumulated during the exponential phase of growth. As expected, we observed
that the culture supernatants of the TCA mutants displayed lower pH as compared to the
wild type strain (Fig. 3.5A).

Figure 3.5 Measurement of pH and acetate accumulation in the stationary phase
growth
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(A) Cells grown in 5 ml TSB to stationary state were centrifuged and supernatant was used to measure the
pH. Error bars represent the SEM of pH of the three biological replicates. (B) Acetate was measured in the
stationary growth phase of each strain following the manufacturer instruction.

This result led us to examine the acetate accumulation and the results showed that
the TCA mutants indeed have increased levels of acetate in the culture supernatant as
compared to the wild type USA300 LAC (Fig 3.5 B).
3.6 Decreased pH does not influence persister formation
Since we observed decreased pH in the culture supernatants of the TCA mutants,
we further sought to examine whether the increased persister fraction is associated with
the acidification of the bacterial culture. To examine this, we used the TSB medium
without glucose that would give the comparable pH in the TCA mutants. The absence of
glucose as resulted in the similar pH with the wild type strain (Fig. 3.6 A), however, the
persister frequency in the TCA mutant gltA and fumC was still increased and similar to
that formed in the TSB medium (Fig. 3.6B).

Figure 3.6 Measurement of pH and persister frequency in the glucose free medium
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(A) The pH was measured in the supernatant of culture grown for 16 in the glucose free medium. (B)
Persister fraction was measured in the stationary state cells grown in glucose free medium. Error bars
represent the SEM of three biological replicates.

These results suggested that the decreased pH in the culture media does not
contribute to the increased persister fraction in the TCA mutants.
3.7 Reduced ATP level does not confer persister cells formation
In S. aureus, increased fraction of persister cells is related to the reduced level of
ATP. To examine if the increased persister cells in the TCA mutants is associated with
reduced ATP, we measured the ATP content in the TCA mutants. Among the TCA
mutants, gltA did not differ from the wild type strain while sucA and fumC mutants
showed significantly reduced ATP level (Fig. 3.7). Therefore, these results suggest that
ATP alone does not determine the persister frequency in S. aureus.

Figure 3.7 Measurement of ATP
ATP level of stationary cultures was tested with BacTiter-GloTM Microbial Cell Viability Assay kit.
Aliquots of 50 µl bacterial suspension in TSB was carefully mixed with equal volume of BacTiterGloTM Reagent and incubated at room temperature for 5 minutes before the luminescence was recorded
with emission at 560 nm. The data represent the average of three independent RFU value per CFUs of three
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biological replicates for each individual sample. Error bars represent SE. Student’s t-test was used to
compare the results of the wild-type to mutants.

3.8 Membrane potential contributes to the persister formation in TCA mutants
A previous study showed increased persister formation in the TCA mutants is
caused due to decreased membrane potential (Wang et al., 2018). To examine this
association, we measured the membrane potential in our test strains. We measured the
membrane potential via flow cytometry using the fluorescent membrane stain DiOC2 (3)
and compared with the USA300 LAC strain. The results showed lower membrane
potential in the TCA mutant fumC than in the USA300 LAC strain (Fig. 3.8A),
suggesting that the reduced membrane potential increases the persister cells formation in
the TCA mutant. To further confirm the role of membrane potential in persister
formation, we measured the persister fraction in the presence of the proton ionophore
carbonyl cyanide m-chlorophenyl hydrazone (CCCP), a known inhibitor of PMF
generation that dissipates H+ ion gradients. In the presence of CCCP, the wild type
USA300 LAC as well as the msaABCR mutant both displayed drastic increase in persister
fraction (Fig 3.8B). Altogether, these results suggest that the reduced membrane potential
contributes to the increased persister formation in S. aureus in the presence of
gentamicin.
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Figure 3.8A Measurement of membrane potential in wild type USA300 LAC and
TCA mutant fumC.
Stationary-phase cells washed twice with PBS were incubated with 3, 3′diethyloxacarbocyanine iodide (DiOC2(3)) for 30 min in room temperature. After
incubation, the cells were subjected to flow cytometry. The data represents the ratio
between channel F3 (red fluorescence) and F1 (green fluorescence), calculated with
FlowJo software.
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Figure 3.8B Measurement of membrane potential and persister formation in the
presence of CCCP
Stationary phase cells pre-incubated for 30 min with different concentrations of carbonyl cyanide mchlorophenyl hydrazone (CCCP) were exposed to gentamycin (20 μg/ml). At 24 h post exposure, the cells
were harvested, washed, and plated for CFU counting. Data represent the percentage of cells survived after
antibiotic exposure to the initial population. Data represent the average of three biological replicates.
Students t-test was used to compare the results of the msaABCR mutant to the wild type. *** p <0.0001.

27

Table 3.2 List of strains and primers used in this study
Strains

Description/Genotype

Source

S. aureus USA300 LAC

Methicillin resistant

Dr. Lindsey Shaw

msaABCR operon deletion

(Sahukhal & Elasri, 2014)

strain
msaABCR

mutant in USA300 LAC
Complementation

msaABCR complement in

(Sahukhal & Elasri, 2014)

msaABCR mutant LAC strain
gltA

SAUSA300_1641

This study

sucA

SAUSA300_1306

This study

fumC

SAUSA300_1801

This study

Primers for qRT-PCR

Sequences (5’

gltA F

AAATCGTTATGAAAGAGCAATG

gltA R

GGATTAGGCTTAAGTGGTTCTT

acnA F

ATAGTGTTGTAACACCTGAATTAT

acnA R

CATATAGAGGTTGATCAGTTACAT

icd F

ATTGCTGACATTTTCTTACAAC

icd R

AGCATCTGAAATATAGTCACCA

sucA F

CAGATGACGTTGAAGCTACTAT

sucA R

CGACGATAACCTACTAAATCAA

sucD F

TTGACTGAAGAAGGTATTGGTC

sucD R

TTGACTGAAGAAGGTATTGGTC

sdhA F

TGAAATTATGACAGCAAATGTAAC

sdhA R

CAATATCTTCATAACGTTTCATCA

sdhB F

TTCTATGGTTATCAATGGTCGT

sdhB R

TAACTGGGAAAGTATTCATTGG

fumC F

TCGAAGTAGTTTATGGTTTTGC

fumC R

CGTATACAATGGCATCTTTCTT
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3’)

CHAPTER IV- DISCUSSION
Persister cells are transiently tolerant to the antibiotics and can resume the
growth when the antibiotic treatment is ceased. This property of the persister cells is
strongly associated with the recurrence of infections that signify its clinical relevance.
In exponential phase, persister cells are produced in smaller fraction while the
frequency increases as the culture enters into the stationary phase (B. P. Conlon et al.,
2016). Similarly, biofilms provide a favorable niche for the generation of slowly
growing, energy depleted antibiotic tolerant persister cells. Given that the S. aureus
chronic infections are mainly biofilm-associated, understanding the mechanisms
underlying the formation of the persister cells is extremely important. In the last two
decades, an increasing number of studies have focused on the mechanisms of persister
formation. However, understanding the persister phenotype has been extremely
challenging because of its small population size and transiency.
In this study, we demonstrate the role of the msaABCR in energy generation in S.
aureus. Likewise, using the mutants of TCA cycle, we show the importance of
metabolism in persister cells formation. The slowly growing S. aureus cells are more
tolerant to antibiotic treatment due to the target inactivation that is caused due to lowenergy state (K. Lewis, 2007, 2010). The reduced energy level is indeed associated also
with the rare persister population that is generated in the exponential growth phase
(Cameron et al., 2018; B. P. Conlon et al., 2016; Shan et al., 2017). These persister
cells display low levels of expression of TCA enzymes (Zalis et al., 2019). In our
study, we show that the deletion of the msaABCR operon in S. aureus was defective in
persister formation, whereas there was an increased persister fraction among the TCA
cycle mutants. These results suggested that the decreased metabolic activity corresponds
with increased persister frequency.
The persister fraction is influenced with the reduced growth rate. In our study,
although the gltA and fumC mutants exhibited reduced growth kinetics, the sucA mutant
showed similar growth kinetics as comparable to the wild type USA300 LAC. These
results indicate that the slow growth of the TCA mutants, gltA and fumC, did not
determine the enhanced persister frequency in those mutants.
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To correlate the importance of ATP with persister frequency, we measured the
ATP level in the tested strains. Although the sucA and fumC mutants showed reduced
ATP content as compared to the USA300 LAC, the gltA mutant showed similar level of
ATP as with the wild type strain. Likewise, we observed a drastic increase in antibiotic
tolerance and reduced intracellular ATP levels with other TCA mutants sucA and fumC.
Our findings from this study indicate that the cellular energy is required for the killing
efficiency of bactericidal antibiotics. However, multiple factors aside from ATP appear to
cause the antibiotic tolerance. Altogether, these results suggested that the reduced ATP is
not the only deterministic factor for persister formation. Previous studies showed that the
persister formation in the TCA mutants are caused due to reduced membrane potential
against ciprofloxacin (Wang et al., 2018). Consistent with this, we also found that the
TCA mutants exhibited reduced membrane potential as compared to the wild type strains.
It is known that the proton motive force (PMF) is required for the uptake of gentamicin
inside the bacterial cells. The increased uptake correlates with the increased killing of the
cells. Therefore, reduced membrane potential in the TCA mutants may have resulted in
increased persister fraction in the presence of gentamicin.
Previous studies have demonstrated the association between persister formation
and membrane potential. For example, enhanced membrane potential led to decreased
persister fraction with enhanced uptake of aminoglycoside antibiotic gentamicin
(Allison et al., 2011; Barraud et al., 2013; Shan et al., 2015). Similarly, decreased
membrane potential was regarded as the major cause for increased persister frequency
in the TCA mutants of S. aureus (Wang et al., 2018). The small-colony variants of S.
aureus display increased resistance towards aminoglycosides due to their low
membrane potential (Kriegeskorte et al., 2014). Similarly, disruption of serA gene led to
increased membrane potential and subsequently decreased persister frequency (Shan et
al., 2015). A previous study demonstrated TCA intermediate metabolite fumarate
mediated the antibiotic persistence in E. coli (Kim et al., 2016). Consistent with these
findings, in our study too, we observed increased persister formation in the presence of
exogenously added fumarate. However, the mechanism underlying this association is not
clearly understood. It is, however, speculated that the accumulated fumarate may cause
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the reduction in generation of PMF thereby increasing the persister fraction in the
presence of gentamicin. We further need to examine this association in the presence of
other antibiotics.
Another study also showed increased antibiotic tolerance caused due to reduced
ATP and membrane potential in S. aureus cells when grown in a polymicrobial culture
(Nabb et al., 2019). Despite these clues, the complete mechanism underlying persister
formation based upon the membrane potential is not understood. Given that the persister
cells are of tremendous clinical significance, understanding the mechanisms of
persister cells is important. S. aureus systemic infections that is mainly associated with
biofilms, which are difficult to treat. So far, eradication of persisters by
aminoglycosides has been achieved in conjunction with the metabolites mannitol and
fructose, by an ATP-independent acyldepsipeptide antibiotic (ADEP4), by drugs in
combination with reactive oxygen species, and by membrane disruption-mediated
clearance in different bacterial systems (Allison et al., 2011; Briers et al., 2014; B. P.
Conlon, 2014; Conlon et al., 2013; Cui et al., 2016). However, clinical efficacies of
these strategies have yet to be elucidated.
Gentamicin is a clinically relevant antibiotic to treat S. aureus infections.
Likewise, the evidences show that the drug has been used in many infections without
any adverse side effects (Pallagrosi, 1973; Richards et al., 1971). In addition,
gentamicin treatment in combination with other drugs has been found to shorten the
treatment duration (Tsuji & Rybak, 2005). These findings suggest that gentamicin is a
potential antibiotic to treat the S. aureus infections. Therefore, we examined the
persister cell formation in S. aureus strains in the presence of gentamicin stress. Since
the deletion of the msaABCR operon led to a deficiency in persister formation in the
presence of gentamicin, this study indicates that the msaABCR operon is a potential
target to eradicate the persister cells and overcome treatment failures. Likewise, since
the disruption of metabolic genes drastically increases persister frequency, future
studies focusing in understanding the complete role of metabolism in the antibiotic
tolerance in different bacterial species would be remarkable to overcome the treatment
failures.
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